• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-216a 通过调节肿瘤干细胞特性和肿瘤微环境发挥抑癌作用。

miR-216a Acts as a Negative Regulator of Breast Cancer by Modulating Stemness Properties and Tumor Microenvironment.

机构信息

Department of Molecular Medicine and Medical Biotechnology, "Federico II" University of Naples, 80131 Naples, Italy.

Percuros BV, 2333 CL Leiden, The Netherlands.

出版信息

Int J Mol Sci. 2020 Mar 27;21(7):2313. doi: 10.3390/ijms21072313.

DOI:10.3390/ijms21072313
PMID:32230799
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7178064/
Abstract

Breast cancer is the most frequent malignancy in females in terms of both incidence and mortality. Underlying the high mortality rate is the presence of cancer stem cells, which divide indefinitely and are resistant to conventional chemotherapies, so causing tumor relapse. In the present study, we identify miR-216a-5p as a downregulated microRNA in breast cancer stem cells vs. the differentiated counterpart. We demonstrate that overexpression of miR-216a-5p impairs stemness markers, mammosphere formation, ALDH activity, and the level of (), which plays a significant role in breast cancer progression and metastasis by leading to the release of pro-inflammatory molecules, such as interleukin 6 (IL-6). Indeed, miR-216a regulates the crosstalk between cancer cells and the cells of the microenvironment, in particular cancer-associated fibroblasts (CAFs), through regulation of the TLR4/IL6 pathway. Thus, miR-216a has an important role in the regulation of stem phenotype, decreasing stem-like properties and affecting the cross-talk between cancer cells and the tumor microenvironment.

摘要

乳腺癌是女性中发病率和死亡率最高的恶性肿瘤。导致高死亡率的原因是癌症干细胞的存在,癌症干细胞无限分裂且对常规化疗具有抗性,从而导致肿瘤复发。在本研究中,我们发现 miR-216a-5p 在乳腺癌干细胞中相较于分化细胞呈下调表达。我们证明过表达 miR-216a-5p 可削弱干细胞标志物、乳腺球形成、ALDH 活性和 () 水平,后者通过导致促炎分子(如白细胞介素 6 (IL-6))的释放,在乳腺癌的进展和转移中起着重要作用。事实上,miR-216a 通过调节 TLR4/IL6 通路来调控癌细胞与微环境细胞(特别是癌相关成纤维细胞,CAFs)之间的串扰。因此,miR-216a 在调节干细胞表型方面发挥着重要作用,降低了干细胞样特性并影响了癌细胞与肿瘤微环境之间的相互作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a37a/7178064/3791ce7f838a/ijms-21-02313-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a37a/7178064/750f632ad753/ijms-21-02313-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a37a/7178064/4f4606efa47b/ijms-21-02313-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a37a/7178064/7931518f00de/ijms-21-02313-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a37a/7178064/c7dfb3572204/ijms-21-02313-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a37a/7178064/3791ce7f838a/ijms-21-02313-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a37a/7178064/750f632ad753/ijms-21-02313-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a37a/7178064/4f4606efa47b/ijms-21-02313-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a37a/7178064/7931518f00de/ijms-21-02313-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a37a/7178064/c7dfb3572204/ijms-21-02313-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a37a/7178064/3791ce7f838a/ijms-21-02313-g005.jpg

相似文献

1
miR-216a Acts as a Negative Regulator of Breast Cancer by Modulating Stemness Properties and Tumor Microenvironment.miR-216a 通过调节肿瘤干细胞特性和肿瘤微环境发挥抑癌作用。
Int J Mol Sci. 2020 Mar 27;21(7):2313. doi: 10.3390/ijms21072313.
2
High-mobility group box 1 released by autophagic cancer-associated fibroblasts maintains the stemness of luminal breast cancer cells.自噬性癌症相关成纤维细胞释放的高迁移率族蛋白B1维持管腔型乳腺癌细胞的干性。
J Pathol. 2017 Nov;243(3):376-389. doi: 10.1002/path.4958. Epub 2017 Sep 21.
3
Targeting LIN28B reprograms tumor glucose metabolism and acidic microenvironment to suppress cancer stemness and metastasis.靶向 LIN28B 重编程肿瘤葡萄糖代谢和酸性微环境,抑制癌症干性和转移。
Oncogene. 2019 Jun;38(23):4527-4539. doi: 10.1038/s41388-019-0735-4. Epub 2019 Feb 11.
4
Loss of miR-6844 alters stemness/self-renewal and cancer hallmark(s) markers through CD44-JAK2-STAT3 signaling axis in breast cancer stem-like cells.miR-6844 的缺失通过 CD44-JAK2-STAT3 信号轴在乳腺癌干细胞样细胞中改变干性/自我更新和癌症特征标志物。
J Cell Biochem. 2023 Aug;124(8):1186-1202. doi: 10.1002/jcb.30441. Epub 2023 Jul 12.
5
Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts.外泌体介导的miR-9递送诱导人乳腺成纤维细胞产生癌症相关的成纤维细胞样特性。
Cell Death Dis. 2016 Jul 28;7(7):e2312. doi: 10.1038/cddis.2016.224.
6
MiR-216a-5p act as a tumor suppressor, regulating the cell proliferation and metastasis by targeting PAK2 in breast cancer.miR-216a-5p 通过靶向 PAK2 调控乳腺癌细胞增殖和转移,发挥抑癌作用。
Eur Rev Med Pharmacol Sci. 2019 Mar;23(6):2469-2475. doi: 10.26355/eurrev_201903_17394.
7
Down-regulation of miR-29b in carcinoma associated fibroblasts promotes cell growth and metastasis of breast cancer.癌相关成纤维细胞中miR-29b的下调促进乳腺癌细胞生长和转移。
Oncotarget. 2017 Jun 13;8(24):39559-39570. doi: 10.18632/oncotarget.17136.
8
Breast cancer-derived exosomes regulate cell invasion and metastasis in breast cancer via miR-146a to activate cancer associated fibroblasts in tumor microenvironment.乳腺癌来源的外泌体通过 miR-146a 调节乳腺癌中的细胞侵袭和转移,从而激活肿瘤微环境中的癌相关成纤维细胞。
Exp Cell Res. 2020 Jun 15;391(2):111983. doi: 10.1016/j.yexcr.2020.111983. Epub 2020 Apr 5.
9
Long non-coding RNA LUCAT1/miR-5582-3p/TCF7L2 axis regulates breast cancer stemness via Wnt/β-catenin pathway.长非编码 RNA LUCAT1/miR-5582-3p/TCF7L2 轴通过 Wnt/β-catenin 通路调节乳腺癌干细胞特性。
J Exp Clin Cancer Res. 2019 Jul 12;38(1):305. doi: 10.1186/s13046-019-1315-8.
10
Post-transcriptional repression of circadian component CLOCK regulates cancer-stemness in murine breast cancer cells.转录后抑制生物钟节律组件调节小鼠乳腺癌细胞的癌症干性。
Elife. 2021 Apr 23;10:e66155. doi: 10.7554/eLife.66155.

引用本文的文献

1
Fibroblasts activated by miRs-185-5p, miR-652-5p, and miR-1246 shape the tumor microenvironment in triple-negative breast cancer via PATZ1 downregulation.由miR-185-5p、miR-652-5p和miR-1246激活的成纤维细胞通过下调PATZ1塑造三阴性乳腺癌的肿瘤微环境。
Cell Mol Life Sci. 2025 Jul 25;82(1):287. doi: 10.1007/s00018-025-05781-y.
2
Targeting WEE1 Kinase for Breast Cancer Therapeutics: An Update.靶向WEE1激酶用于乳腺癌治疗:最新进展
Int J Mol Sci. 2025 Jun 13;26(12):5701. doi: 10.3390/ijms26125701.
3
Targeting Glioblastoma Stem Cells: A40s Aptamer-NIR-Dye Conjugate for Glioblastoma Visualization and Treatment.

本文引用的文献

1
The Role of Exo-miRNAs in Cancer: A Focus on Therapeutic and Diagnostic Applications.外泌体 miRNA 在癌症中的作用:治疗和诊断应用的焦点。
Int J Mol Sci. 2019 Sep 21;20(19):4687. doi: 10.3390/ijms20194687.
2
Cancer Cell Lines Are Useful Model Systems for Medical Research.癌细胞系是医学研究中有用的模型系统。
Cancers (Basel). 2019 Aug 1;11(8):1098. doi: 10.3390/cancers11081098.
3
Downregulation of microRNA-196a inhibits stem cell self-renewal ability and stemness in non-small-cell lung cancer through upregulating GPX3 expression.
靶向胶质母细胞瘤干细胞:用于胶质母细胞瘤可视化和治疗的A40s适配体-近红外染料偶联物
Biomolecules. 2025 May 27;15(6):768. doi: 10.3390/biom15060768.
4
Overcoming temozolomide resistance in glioma: recent advances and mechanistic insights.克服胶质瘤中的替莫唑胺耐药性:最新进展与机制洞察
Acta Neuropathol Commun. 2025 Jun 5;13(1):126. doi: 10.1186/s40478-025-02046-4.
5
Exosomal transfer of pro-pyroptotic miR-216a-5p exacerbates anthracycline cardiotoxicity through breast cancer-heart pathological crosstalk.促焦亡性miR-216a-5p的外泌体转移通过乳腺癌-心脏病理串扰加剧蒽环类药物心脏毒性。
Signal Transduct Target Ther. 2025 May 14;10(1):157. doi: 10.1038/s41392-025-02245-4.
6
Ex.50.T aptamer impairs tumor-stroma cross-talk in breast cancer by targeting gremlin-1.例50:T适体通过靶向gremlin-1削弱乳腺癌中的肿瘤-基质相互作用。
Cell Death Discov. 2025 Mar 11;11(1):94. doi: 10.1038/s41420-025-02363-6.
7
MCT4-driven CAF-mediated metabolic reprogramming in breast cancer microenvironment is a vulnerability targetable by miR-425-5p.MCT4驱动的癌相关成纤维细胞介导的乳腺癌微环境中的代谢重编程是一个可被miR-425-5p靶向的脆弱点。
Cell Death Discov. 2024 Mar 14;10(1):140. doi: 10.1038/s41420-024-01910-x.
8
Crosstalk and plasticity driving between cancer-associated fibroblasts and tumor microenvironment: significance of breast cancer metastasis.肿瘤相关成纤维细胞与肿瘤微环境间的串扰和可塑性:乳腺癌转移的意义。
J Transl Med. 2023 Nov 17;21(1):827. doi: 10.1186/s12967-023-04714-2.
9
Molecular mechanisms of microRNA-216a during tumor progression.微小RNA-216a在肿瘤进展过程中的分子机制。
Cancer Cell Int. 2023 Feb 5;23(1):19. doi: 10.1186/s12935-023-02865-2.
10
Therapeutic Targeting of TLR4 for Inflammation, Infection, and Cancer: A Perspective for Disaccharide Lipid A Mimetics.针对炎症、感染和癌症的TLR4治疗靶点:二糖脂A模拟物的前景
Pharmaceuticals (Basel). 2022 Dec 23;16(1):23. doi: 10.3390/ph16010023.
下调 microRNA-196a 通过上调 GPX3 表达抑制非小细胞肺癌干细胞自我更新能力和干性。
Int J Biochem Cell Biol. 2019 Oct;115:105571. doi: 10.1016/j.biocel.2019.105571. Epub 2019 Jul 25.
4
MicroRNA modulated networks of adaptive and innate immune response in pancreatic ductal adenocarcinoma.微小 RNA 调节胰腺导管腺癌中适应性和先天免疫反应的网络。
PLoS One. 2019 May 31;14(5):e0217421. doi: 10.1371/journal.pone.0217421. eCollection 2019.
5
Highly Homogeneous Biotinylated Carbon Nanodots: Red-Emitting Nanoheaters as Theranostic Agents toward Precision Cancer Medicine.高度均一的生物素化碳纳米点:红色发光纳米加热器作为精准癌症医学的治疗诊断一体化试剂。
ACS Appl Mater Interfaces. 2019 Jun 5;11(22):19854-19866. doi: 10.1021/acsami.9b04925. Epub 2019 May 24.
6
LncRNA DANCR contributes to tumor progression via targetting miR-216a-5p in breast cancer: lncRNA DANCR contributes to tumor progression.长链非编码 RNA DANCR 通过靶向乳腺癌中的 miR-216a-5p 促进肿瘤进展:长链非编码 RNA DANCR 促进肿瘤进展。
Biosci Rep. 2019 Apr 23;39(4). doi: 10.1042/BSR20181618. Print 2019 Apr 30.
7
Propofol Reduced Mammosphere Formation of Breast Cancer Stem Cells via PD-L1/Nanog .丙泊酚通过 PD-L1/Nanog 减少乳腺癌干细胞的球体形成。
Oxid Med Cell Longev. 2019 Feb 14;2019:9078209. doi: 10.1155/2019/9078209. eCollection 2019.
8
Tumor-infiltrating mesenchymal stem cells: Drivers of the immunosuppressive tumor microenvironment in prostate cancer?肿瘤浸润间充质干细胞:前列腺癌免疫抑制肿瘤微环境的推动者?
Prostate. 2019 Feb;79(3):320-330. doi: 10.1002/pros.23738. Epub 2018 Nov 28.
9
miR-216a-5p inhibits malignant progression in small cell lung cancer: involvement of the Bcl-2 family proteins.微小RNA-216a-5p抑制小细胞肺癌的恶性进展:Bcl-2家族蛋白的参与
Cancer Manag Res. 2018 Oct 18;10:4735-4745. doi: 10.2147/CMAR.S178380. eCollection 2018.
10
Tumor-associated macrophages in breast cancer: Innocent bystander or important player?乳腺癌中的肿瘤相关巨噬细胞:无辜的旁观者还是重要的参与者?
Cancer Treat Rev. 2018 Nov;70:178-189. doi: 10.1016/j.ctrv.2018.08.010. Epub 2018 Aug 28.